AZmed, one of the leading AI companies in medical imaging, announced that it has received two new U.S. Food and Drug Administration (FDA) clearances for its AI tool AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest X-rays for lung nodules and...
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By bringing together pathology teams, IT systems, and AI into a single, integrated platform, Fusion aims to eliminate workflow silos, enhance diagnostic accuracy,...
AIRA Matrix, a leading innovator in AI-driven QC solutions, and Gestalt, an industry leader in IMS and digital pathology, have formed a strategic partnership to bring AIRA Matrix's advanced AI solution, AIRAQC, to Gestalt's PathFlow. This collaboration marks a significant step toward enhancing diagnostic precision and efficiency in laboratories...
Leveraging NVIDIA's Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization
Medical imaging faces several critical challenges. Imaging modalities like MRI, PET, and CT are used in over five hundred million patients annually for diagnosis and treatment, involving long scan times and/or potentially high radiation and...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group, one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors,...
Caliber has launched four digital solutions that strengthen its portfolio and position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate AI and next-generation technologies to reinforce Caliber's commitment to future-proofing the life sciences industry through holistic digital enablement and optimized compliance.
With over 23 years of...
Flagship Pioneering, the bioplatform innovation company, unveiled Lila Sciences, a company building the world's first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences. The company, which was founded in Flagship's labs in 2023, is pioneering an advanced form of AI that can not only...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-assisted drug discovery engine, Hu-mAtrIxTM. This new platform, powered by advanced artificial intelligence, integrates seamlessly with the company's proprietary Harbour Mice® technology platform, aiming to accelerate antibody discovery across...
ARUP Laboratories announced the expansion of its groundbreaking AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides. With this expansion, ARUP Laboratories will become the first and only laboratory to apply AI-augmented screening to the entire ova and parasite testing process.
"By utilizing an AI-augmented...
Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, announced the company will build on its recent business development momentum by soliciting Requests-For-Proposal (“RFPs”) for license or sale of its PsyAI™ trademark portfolio as a...
